Mucinex and Humibid will soon be the only long-acting guaifenesin products left standing

July 2007

Mucinex and Humibid will soon be the only long-acting guaifenesin products left standing.

The FDA already ordered all other SINGLE-ingredient long-acting guaifenesin products off the market in 2003 when Mucinex came out.

Now they are also targeting unapproved COMBO products that contain long-acting guaifenesin (Guaifenex, Crantex, etc).

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote